ImpactOS
See an example

Bristol-Myers Squibb Company

Companies and groups · United States

In these lists: Biggest budgets, Medicines

Declared lobbying cost
€2,500,000 – €2,749,999 Financial year 01/2025-12/2025
Commission meetings
10
Full-time staff on EU lobbying
4
European Parliament access passes
7
Registered since
26 Sept 2011
Public records onlyWhat this means

Every profile, record and figure comes from documents published by EU institutions, national authorities, courts, ethics bodies, the EU Transparency Register or established news outlets. We use no leaks, private data or anonymous tips. AI helps us gather and cross-check sources but never decides anyone's guilt: each record keeps its exact legal status and links to its source, so you can check it yourself

Registering is a legal transparency duty, not a sign of wrongdoing. Budgets and meetings show access, not influence on any particular decision. Register figures as declared on 11 Nov 2026

Fields of interest

Banking and financial services, Budget, Business and industry, Competition, Consumers, Customs, Digital economy and society, Economy, finance and the euro, Employment and social affairs, Environment, External relations, Institutional affairs, Justice and fundamental rights, Public health, Research and innovation, Single market, Taxation, Trade

Medicines and food topics they name

EU medicines law

EU laws and policies they declare following15
  • 28th Regime for Innovative Companies
  • European Innovation Act
  • Public Procurement Act
  • European Research Area Act
  • European Biotech Act I
  • European Biotech Act II
  • Omnibus on taxation
  • Interest and Royalties Directive (Council Directive 2003/49/EC)
  • Tax Merger Directive (Council Directive 2009/133/EC)
  • Parent-Subsidiary Directive (Council Directive 2011/96/EU)
  • Anti-Tax Avoidance Directive (Council Directive (EU) 2016/1164)
  • Tax Dispute Resolution Mechanisms Directive (Council Directive 2017/1852).
  • Framework for Income Taxation (BEFIT)
  • Communication on better regulation
  • Update of antitrust procedural rules

Meetings with the Commission

Meetings with Commissioners or their Cabinets since 1 December 2024, as the Commission publishes them

  1. With the Commissioner

    Olivér Várhelyi

    Life Sciences Roundtable

    Published record
  2. With the Commissioner

    Olivér Várhelyi

    Roundtable on the health package

    Published record
  3. With the Cabinet

    Olivér Várhelyi

    Roundtable on the health package

    Published record
  4. With the Cabinet

    Maroš Šefčovič

    Latest developments in EU-US relations

    Published record
  5. With the Cabinet

    Ursula von der Leyen

    Exchange on Biotech Act and strategic policy issues

    Published record
  6. With the Cabinet

    Ekaterina Zaharieva

    Life sciences

    Published record
  7. With the Commissioner

    Olivér Várhelyi

    Leiden Car-T site visit

    Published record
  8. With the Commissioner

    Olivér Várhelyi

    Health Package – Biotech Act

    Published record
  9. With the Cabinet

    Olivér Várhelyi

    Health Package – Biotech Act

    Published record
  10. With the Cabinet

    Ursula von der Leyen

    Biotechnology acts

    Published record

Official entries

Checked against sources on 11 Nov 2026